Egyptian Drug Authority signs cooperation protocol to enhance training in the medical sector
The activities of the fifth edition of the Africa Health ExCon 2026 witnessed a new step aimed at developing the health sector in Egypt. The Egyptian Drug Authority signed a strategic cooperation protocol with GlaxoSmithKline Egypt, as part of the state's ongoing efforts to upgrade medical services.
This protocol primarily aims to enhance training and professional development programs for workers in the pharmaceutical sector. Through this partnership, the Authority seeks to exchange scientific and technical expertise, which contributes to raising the efficiency of human resources and developing their skills in accordance with the latest international standards.
This cooperation comes at a time when Egypt is seeking to strengthen its position as a regional hub for pharmaceutical industries on the African continent. It is expected that this training will lead to improving the quality of services provided to citizens and ensuring the availability of highly efficient medicines that meet the requirements of the local and international market.
This step is part of a broader vision adopted by the Egyptian Drug Authority to strengthen partnership with the private sector. The Authority emphasizes that cooperation with international companies contributes to the transfer of modern technology and the localization of vital pharmaceutical industries within Egypt.
At the conclusion of the events, participants in the exhibition praised the importance of these agreements in supporting the sustainability of the medical sector. The training programs resulting from this protocol are expected to begin in the coming period, reflecting the state's commitment to developing the health system to serve the Egyptian society.